1. Home
  2. SBFM vs ZCMD Comparison

SBFM vs ZCMD Comparison

Compare SBFM & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • ZCMD
  • Stock Information
  • Founded
  • SBFM 2006
  • ZCMD 2012
  • Country
  • SBFM United States
  • ZCMD China
  • Employees
  • SBFM N/A
  • ZCMD N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • SBFM Health Care
  • ZCMD Real Estate
  • Exchange
  • SBFM Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • SBFM 3.7M
  • ZCMD 3.4M
  • IPO Year
  • SBFM N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • SBFM $3.00
  • ZCMD $1.54
  • Analyst Decision
  • SBFM
  • ZCMD
  • Analyst Count
  • SBFM 0
  • ZCMD 0
  • Target Price
  • SBFM N/A
  • ZCMD N/A
  • AVG Volume (30 Days)
  • SBFM 153.8K
  • ZCMD 2.3M
  • Earning Date
  • SBFM 11-11-2024
  • ZCMD 01-01-0001
  • Dividend Yield
  • SBFM N/A
  • ZCMD N/A
  • EPS Growth
  • SBFM N/A
  • ZCMD N/A
  • EPS
  • SBFM N/A
  • ZCMD N/A
  • Revenue
  • SBFM $30,481,982.00
  • ZCMD $19,433,945.00
  • Revenue This Year
  • SBFM $86.70
  • ZCMD N/A
  • Revenue Next Year
  • SBFM $126.76
  • ZCMD N/A
  • P/E Ratio
  • SBFM N/A
  • ZCMD N/A
  • Revenue Growth
  • SBFM 109.82
  • ZCMD 37.33
  • 52 Week Low
  • SBFM $2.42
  • ZCMD $1.00
  • 52 Week High
  • SBFM $660.00
  • ZCMD $11.00
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 46.45
  • ZCMD 42.34
  • Support Level
  • SBFM $2.85
  • ZCMD $1.82
  • Resistance Level
  • SBFM $3.05
  • ZCMD $2.15
  • Average True Range (ATR)
  • SBFM 0.15
  • ZCMD 0.33
  • MACD
  • SBFM 0.02
  • ZCMD -0.08
  • Stochastic Oscillator
  • SBFM 43.59
  • ZCMD 0.00

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

Share on Social Networks: